Becton, Dickinson and Co. | BDX - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Agilent USD 2.29B 20M 2026-06
Align Technology USD 1.91B 2.74M 2026-06
AngioDynamics USD 71.96M 3.68M 2025-09
Baxter International USD 3.59B 102M 2026-06
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Bio-Rad Laboratories USD 961.3M 44.3M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Cooper Companies USD 1.8B 209M 2026-03
Danaher USD 8.1B 645M 2026-06
Dentsply International USD 1.18B 22M 2026-06
Dexcom USD 2.36B 133.9M 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Globus Medical USD 479.35M 3.12M 2026-06
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
Intuitive Surgical USD 2.58B 65.1M 2026-06
J&J USD 54.9B 2.82B 2026-06
Medtronic USD 11.66B 2.16B 2026-03
Solventum Corp USD 3.66B 317M 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
Terumo JPY 413.28B 127.46B 2026-06
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06